/Lists

Biotech Series B Investors & VC Firms

724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.

ARCH Venture Partners
ChicagoSeed–Series C$50K – $250M
46 people
Atinum Investment Co. Ltd.
SeoulSeries B–Growth$100K – $2M
44 people
CDP Venture Capital
RomaPre-Seed–Growth
44 people
Inveready Technology Investment Group
San SebastiánPre-Seed–Late Stage$108K – $21.6M
60 people
Foresite Capital
West HollywoodSeed–Late Stage
44 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
SoftBank Group
TokyoSeries B–Growth
23 people
Future Planet Capital
LondonSeed–Growth
31 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
61 people
Bayern Kapital
LandshutSeed–Late Stage$275K – $55M
46 people
Paladin Capital Group
WashingtonSeed–Growth$100K – $5M
65 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
71 people
Addor Capital
NanjingSeed–Series B
44 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
58 people
IMM Investment Japan
TokyoSeed–Growth
21 people
Nippon Venture Capital
TokyoPre-Seed–Growth$300K – $5M
29 people
HOF Capital
New YorkPre-Seed–Growth$500K – $10M
45 people
Portfolia
San MateoSeed–Series B
58 people
SBI Investment Korea Co. Ltd.
SeoulSeries A–Series C$200K – $10M
33 people
Polaris Partners
BostonSeed–Growth$500K – $5M
45 people
Elaia
ParisSeed–Series C$108K – $1.6M
45 people
Third Rock Ventures
BostonSeed–Series C$100K – $5M
62 people
Dementia Discovery Fund
LondonSeed–Late Stage
81 people
Cultivation Capital
St. LouisSeed–Series B$100K – $3.5M
37 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.